hTERT gene methylation in circulating DNA, tumor, and surrounding tissue in breast cancer: a prospective study
Keywords:
Cell-free nucleic acids, Telomerase, Methylation, Breast neoplasms, Liquid biopsy, Telomeres, Breast cancer, Liquid biopsiesAbstract
BACKGROUND: The human telomerase reverse transcriptase (hTERT) enzyme, encoded by the hTERT gene, synthesizes protective telomeric sequences on chromosomes and plays a fundamental role in cancer formation. Methylation of the hTERT gene has an upregulatory effect, increasing hTERT enzyme synthesis and allowing continuous tumor cell division. OBJECTIVE: In a group of patients with breast cancer, we aimed to analyze the methylation status of hTERT in the tumor, surrounding tissue, and circulating free deoxyribonucleic acid (cfDNA) of blood collected on the day of mastectomy and then approximately one year later. DESIGN AND SETTING: A prospective study was conducted at a university hospital in Rio de Janeiro, Brazil. METHODS: Samples were collected from 15 women with breast cancer on the day of mastectomy and approximately one year postoperatively. cfDNA was analyzed by sodium bisulfite conversion, followed by polymerase chain reaction, electrophoresis, and silver nitrate staining. RESULTS: Methylation of hTERT was detected in the tumors and surrounding tissues of all 15 patients. Five patients displayed hTERT methylation in the cfDNA from the blood of the first collection. Of the ten patients who returned for the second collection, three showed methylation. Two patients with methylation in the first collection did not display methylation in the second collection. One patient with no methylation in the first collection displayed methylation in the second collection, and one patient had a diminished level of methylation in the second collection. CONCLUSION: Only one-third of patients displayed methylation in their cfDNA, which may be related to the success of chemotherapy.
Downloads
References
Nguyen E, Richerolle A, Sánchez-Bellver J, Varennes J, Ségal-Bendirdjia E. hTERT DNA Methylation Analysis Identifies a Biomarker for Retinoic Acid-Induced hTERT repression in Breast Cancer Cell Lines. Biomedicines. 2022;10(3):695. PMID: 35327497; https://doi.org/10.3390/biomedicines10030695.
Welfer GA, Borin VA, Cortez LM et al. Altered Nucleotide Insertion Mechanisms of Disease-Associated TERT Variants. Genes. 2023;14(2):281. PMID: 36833208; https://doi.org/10.3390/genes14020281.
Liu T, Li S, Xia C, Xu D.TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance. Front Immunol. 2023;13:1071390. PMID: 36713366; https://doi.org/10.3389/fimmu.2022.1071390.
Taheri M, Ghafouri Fard S, Najafi S, et al. Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. Cancer Cell Int. 2022;22(1):258. PMID: 35974340; https://doi.org/10.1186/s12935-022-02678-9.
Leão R, Apolónio JA, Lee D, et al. Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer. J Biomed Sci. 2018;25(1):22. PMID: 29526163; https://doi.org/10.1186/s12929-018-0422-8.
Pfeiferova L, Safarikova M, Ulrych J, et al.Circulating Cell-Free DNA Extraction from Liquid Biopsy for Cancer Research. Folia Biol. 2022;68(4):153-7. PMID: 36871171.
Hassan F, Wang JH, Cullinane C, et al. Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancer. Surg Oncol. 2022;42:101753. PMID: 35594723; https://doi.org/10.1016/j.suronc.2022.101753.
Stejskal P, Goodarzi H, Srovnal J, et al. Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Mol Cancer. 2023;22(1):15. PMID: 36681803; https://doi.org/10.1186/s12943-022-01710-w.
Song P, Wu LR, Yan YH, et al. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. Nat Biomed Eng. 2022;6(3):232-45. PMID:35102279;https://doi.org/10.1038/s41551-021-00837-3.
Gao Q, Zeng Q, Wang Z, et al.Circulating cell-free DNA for cancer early detection. Innovation. 2022;3(4):100259. PMID: 35647572; https://doi.org/10.1016/j.xinn.2022.100259.
Birknerova N, Mancikova V, Paul ED, et al. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer. Cancers. 2022;14(19):4882. PMID: 36230805; https://doi.org/10.3390/cancers14194882.
Chantre-Justino M, Delmonico L, Lage C, et al. Tracking the history of circulating nucleic acids for cancer research in Brazil: A systematic review. Braz J Health Biomed Sci. 2021;20(2):135-43. https://doi.org/10.12957/bjhbs.2021.63966.
Maccormick TM, Carvalho CES, Bravo Neto GP, Carvalho MGC. Comparative analysis of glutathione transferase genetic polymorphism, Helicobacter pylori and Epstein-Barr virus between the tumor area and the proximal and distal resection margins of gastric cancer. Rev Col Bras Cir. 2018;46(1):e2068. PMID: 30726307; https://doi.org/10.1590/0100-6991e-20192068.
Pestaner JP, Bibbo M, Bobroski L, Seshamma T, Bagasra O. Potential of the in situ polymerase chain reaction in diagnostic cytology. Acta Cytol. 1994;38(5):676-80. PMID: 8091896.
Haraguchi K, Yada N, Sato S, et al. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis. APMIS. 2017;125(9):797-807. PMID: 28766760;https://doi.org/10.1111/apm.12723.
Silva MM, Fonseca CO, Moura-Neto R, et al. Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy. Genet Mol Res. 2013;12(2):1621-30. PMID: 23765968;https://doi.org/10.4238/2013.May.14.2.
Dratwa M, Wysoczanska B, Łacina P, Kubik T, Bogunia-Kubik K. TERT—Regulation and Roles in Cancer Formation. Front Immunol. 2020;11:589929. PMID: 33329574; https://doi.org/10.3389/fimmu.2020.589929.
Chen X, Gole J, Gore A, et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat. Commun. 2020;11(1):3475. PMID: 32694610; https://doi.org/10.1038/s41467-020-17316-z.
Masood S, El-Gabry E, Zhang C, Wang Z. The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation. Diagn Cytopathol. 2016;44(8):670-5. PMID: 27229911; https://doi.org/10.1002/dc.23505.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
